CIBC Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.9M Buy
37,158
+29,978
+418% +$7.96M 0.04% 297
2026
Q1
$787K Buy
7,180
+342
+5% +$48.7K ﹤0.01% 728
2025
Q4
$1.14M Buy
6,838
+1,988
+41% +$333K ﹤0.01% 694
2025
Q3
$950K Hold
4,850
– – ﹤0.01% 685
2025
Q2
$439K Hold
4,850
– – ﹤0.01% 786
2025
Q1
$289K Buy
4,850
+93
+2% +$8.6K ﹤0.01% 885
2024
Q4
$630K Buy
4,757
+237
+5% +$22.2K ﹤0.01% 718
2024
Q3
$237K Buy
+4,520
New +$212K ﹤0.01% 993

Other funds holding ALAB

CIBC Asset Management's ALAB Position: Q2 2026 in Review

CIBC Asset Management increased its Astera Labs (ALAB) stake by 418% in Q2 2026, buying an estimated $7.96M and bringing the position to 37,158 shares worth $17.9M. The position accounts for 0.04% of the portfolio, ranked #297.

CIBC Asset Management first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • CIBC Asset Management held 37,158 shares of Astera Labs worth $17.9M as of Q2 2026.
  • CIBC Asset Management bought 29,978 Astera Labs shares in Q2 2026, an estimated $7.96M.
  • Astera Labs made up 0.04% of CIBC Asset Management's portfolio in Q2 2026, its #297 holding.
  • CIBC Asset Management first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.